Proteasome inhibition and its therapeutic potential in multiple myeloma
Proteasome inhibition and its therapeutic potential in multiple myeloma
About this item
Full title
Author / Creator
Publisher
New Zealand: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
Reviews the preclinical and clinical development of bortezomib as the underpinning for a systematic review of the large number of clinical trials that are beginning to shed some light on the full therapeutic potential of this drug in treating multiple myeloma. Discusses current understanding of the mechanism of action of this agent and the novel pr...
Alternative Titles
Full title
Proteasome inhibition and its therapeutic potential in multiple myeloma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bfa5dae794bc4d58b562ef9039d50e04
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bfa5dae794bc4d58b562ef9039d50e04
Other Identifiers
ISSN
1177-5475,1177-5491
E-ISSN
1177-5475,1177-5491
DOI
10.2147/BTT.S3419
